Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies and for the preparation of autologous platelet-rich plasma (PRP) from the patient’s own blood, to be used in procedures.

Regen Lab follows a stringent approach to regulatory matters and Quality System Management. They operate within the framework of the ISO 13485 Norms, which combines the requirements medical device manufacturers must incorporate into their management systems. Thier Quality System is also audited in accordance with the requirements of Annex II of the Directive 93/42/EEC on medical devices.